Description：

LCZ696, consisting of valsartan and sacubitril in 1:1 molar ratio, is an orally bioavailable, dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) for hypertension and heart failure. Phase 3.

Chemical Information：

Molecular Weight (MW)		915.98
Formula		C24H29N5O3.C24H29NO5.5/2H2O.3Na
CAS No.		936623-90-4
Solubility (25°C) *	DMSO	30 mg/mL warmed (32.75 mM)
	Water	100 mg/mL warmed (109.17 mM)
	Alcohol	9 mg/mL warmed (9.82 mM)

Preparing Stock Solutions

Concentration Volume (DMSO) Mass	1 mg	5 mg	10 mg
1 mM	1.0917 mL	5.4586 mL	10.9173 mL
5 mM	0.2183 mL	1.0917 mL	2.1835 mL
10 mM	0.1092 mL	0.5459 mL	1.0917 mL
50 mM	0.0218 mL	0.1092 mL	0.2183 mL

Bought notes(bought amounts latest0)

No one bought this product

Total 0 records, divided into1 pages. First Prev Next Last